[Experience with the use of a new autonomic drug butyroxan in patients with gastroduodenal pathology and autonomic dysfunction].
N V
NV
Gonchar
M I
MI
Sokolova
E G
EG
Klocheva
T N
TN
Mikueva
D000293:Adolescent; D001341:Autonomic Nervous System / Q000187:drug effects; D001342:Autonomic Nervous System Diseases / Q000150:complications / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D004146:Dioxanes / Q000627:therapeutic use*; D004147:Dioxins / Q000627:therapeutic use*; D004381:Duodenal Ulcer / Q000150:complications / Q000188:drug therapy*; D004382:Duodenitis / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005759:Gastroenteritis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male
D004146:Dioxanes; D004147:Dioxins; C021293:butyroxan
Opyt primeneniia novogo vegetotropnogo preparata butiroksana u bol'nykh s gastroduodenal'noĭ patologieĭ i vegetativnoĭ disfunktsiei.